Physician profile
Patrick Timothy Strickland
NPI 1568957561
$2,293.46
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $522 · 2022: $836 · 2023: $469 · 2024: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $675.27 | 2021-2024 | Onyx Frontier, Resolute Onyx, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $411.20 | 2022-2023 | Mitraclip, Aveir, Confirm Rx |
| Edwards Lifesciences Corporation | $238.39 | 2022 | |
| Amgen INC. | $194.34 | 2023-2024 | Repatha |
| Shockwave Medical, INC | $178.78 | 2021 | |
| Lantheus Medical Imaging, INC. | $156.97 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $129.37 | 2021-2022 | |
| Heartflow, INC. | $115.61 | 2024 | |
| Pfizer INC. | $113.08 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2022 | |
| W. L. Gore & Associates, INC. | $17.95 | 2023 | Gore Cardioform Septal Occluder |
| Novartis Pharmaceuticals Corporation | $16.55 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.